NCT02322125

Brief Summary

Powered exoskeletons have emerged recently, promising to offer walking to individuals with severe spinal cord injury who are unable to walk. We will use the ReWalk exoskeleton to train walking in individuals with chronic, severe spinal cord injury (SCI). We will determine the characteristics of individuals who most benefit from such training, and identify the neuroplasticity induced by the training. We will further determine the feasibility of the ReWalk for home and community ambulation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2014

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2014

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

December 17, 2014

Completed
5 days until next milestone

First Posted

Study publicly available on registry

December 22, 2014

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 20, 2018

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 26, 2018

Completed
3.1 years until next milestone

Results Posted

Study results publicly available

October 14, 2021

Completed
Last Updated

October 14, 2021

Status Verified

October 1, 2021

Enrollment Period

4.2 years

First QC Date

December 17, 2014

Results QC Date

December 5, 2019

Last Update Submit

October 13, 2021

Conditions

Keywords

walkinglocomotionrehabilitation

Outcome Measures

Primary Outcomes (1)

  • Physiological Cost Index (PCI) Ratio

    PCI is defined as the change in heart rate from the average at rest to the average in the last two minutes of the 6 minute walk test is divided by the average speed during the last two minutes of walking to give a measure of heartbeats/minute. The ratio between this measure while walking in the Rewalk and the same measure while performing the test using a wheelchair will be calculated. (Walk/wheelchair)

    End of training:12-14 weeks from baseline

Secondary Outcomes (8)

  • 10 Meter Walk Test

    End of training (at 12 weeks for 10 participants and 6 weeks for 1) and at follow-up (2-3 months from end of training)

  • Max Distance

    End of training:12-14 weeks from baseline

  • Limits of Stability - Sitting

    Baseline, Mid point-6 weeks from baseline, End training:12-14 weeks from baseline

  • Sitting Sway

    Baseline, Mid-point:6 weeks from baseline, End training:12-14 weeks from baseline

  • McGill Pain Questionnaire

    Baseline, midpoint:6 weeks from baseline, end training:12-14 weeks from baseline

  • +3 more secondary outcomes

Study Arms (1)

ReWalk training

EXPERIMENTAL

ReWalk exoskeleton training: 1.5 hr/day, 4 days/week, for 12-14 weeks (approximately 50 training sessions). Participants will progress through the following: sit-to-stand, stand-to-sit, standing balance and weight shift, walking on smooth ground, stopping, turning while walking, walking on rough ground, ascending and descending slopes, ascending and descending steps and curbs.

Device: ReWalk

Interventions

ReWalkDEVICE

Intensive training with the ReWalk to negotiate smooth ground, rough terrain indoors and outdoors, ascending and descending slopes and steps, in a home setting and in the community.

ReWalk training

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • non-progressive spinal cord injury ≥1 year post-injury
  • Body height between 5'3" and 6'4"
  • Body weight ≤82 kg
  • Uses wheelchair as primary mode of mobility
  • If able to walk, walks at ≤0.4 m/s
  • Arm strength sufficient to control forearm crutches
  • Agree to attend intensive training of 1.5 hr/day, 4 days/wk for 14 weeks, plus testing pre and post training of approximately 2 weeks each

You may not qualify if:

  • Contractures at the hip, knee or ankle that interferes with fitting into the ReWalk
  • Fractures within the last 2 years
  • Osteoporosis in the legs (t-score ≤-3.0)
  • Severe postural hypotension
  • Severe spasticity that interferes with use of the ReWalk
  • Active pressure sores
  • Pregnancy
  • Severe head injury
  • Conditions that preclude intensive exercise (such as high blood pressure)
  • Presence of conditions contraindicated for transcranial magnetic stimulation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Alberta

Edmonton, Alberta, T6G 2G4, Canada

Location

Related Publications (2)

  • Khan AS, Livingstone DC, Hurd CL, Duchcherer J, Misiaszek JE, Gorassini MA, Manns PJ, Yang JF. Retraining walking over ground in a powered exoskeleton after spinal cord injury: a prospective cohort study to examine functional gains and neuroplasticity. J Neuroeng Rehabil. 2019 Nov 21;16(1):145. doi: 10.1186/s12984-019-0585-x.

    PMID: 31752911BACKGROUND
  • Manns PJ, Hurd C, Yang JF. Perspectives of people with spinal cord injury learning to walk using a powered exoskeleton. J Neuroeng Rehabil. 2019 Jul 19;16(1):94. doi: 10.1186/s12984-019-0565-1.

MeSH Terms

Conditions

Spinal Cord Injuries

Condition Hierarchy (Ancestors)

Spinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemWounds and Injuries

Limitations and Caveats

Small number of participants suggests data should be interpreted with caution.

Results Point of Contact

Title
Dr. Jaynie Yang
Organization
University of Alberta

Study Officials

  • Jaynie F Yang, PhD

    University of Alberta

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 17, 2014

First Posted

December 22, 2014

Study Start

June 1, 2014

Primary Completion

August 20, 2018

Study Completion

September 26, 2018

Last Updated

October 14, 2021

Results First Posted

October 14, 2021

Record last verified: 2021-10

Data Sharing

IPD Sharing
Will not share

Locations